Retinal imaging is an efficient way for the optometrist to assess eye health using a high-resolution camera and imaging systems. Retinal imaging takes a digital picture of the eye and shows detailed imaging of the retina, optic disk, and blood vessels of the eye. Retinal imaging exploits high definition imaging devices to generate magnified images of the retina. It helps in the diagnosis of age-related macular degeneration, glaucoma, and optic nerve damages.
The report also covers the influence of the COVID-19 pandemic on the Retinal Imaging market. The pandemic has dynamically affected all aspects of life on a global scale along with drastic changes in the economy and market conditions. The report covers the currently fluctuating market scenario along with present and future assessment of the COVID-19 impact. The report encompasses the historical data, company overview, financial standing, and necessary information about the new and key players of the market.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/262
Retinal Imaging Market: Dynamics
The growing incidence of retinal disorders across the glove, increased efficiency of diagnosis and treatment, and evolution of the retinal imaging systems are projected to propel the industry’s growth over the coming years. Additionally, ultra-modern healthcare infrastructure and convenient reimbursement policies are also contributing to the growth of the Retinal Imaging Market.
COVID-19 Impact Analysis:
This report is the latest document encompassing the massive changes that took place in the Retinal Imaging market following the emergence of the COVID-19 pandemic. The pandemic has drastically affected the global economic landscape, thereby disrupting the operating mechanism of the Retinal Imaging market. The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment. Therefore, the report fully covers the profound impact of COVID-19 on this industry, with a special focus on the affected industry segments. However, the market is expected to regain momentum in the post-COVID-19 era. The report also offers an initial and future impact assessment of the pandemic on the Retinal Imaging industry. Hence, the vital COVID-19 insights offered by the report are expected to help organizations manage their businesses effectively in extreme economic uncertainties.
The rising adoption of smart devices increases the incidences of ophthalmic disorders, and the rising geriatric population is causing a surge in the patient pool of age-related macular degeneration. In turn, this is increasing the demand for advanced diagnostic measures for early detection of the disorders. With the launch of new retinal imaging solutions over time, the market has witnessed significant growth over the last couple of years.
The most common ophthalmic disorders are age-related macular degeneration, macular edema, and diabetic neuropathy, among others. With the rising prevalence of diabetes globally, there is a massive surge in the patient pool of people with diabetic complications. Diabetic retinopathy is among the most common complications of diabetes. The severity of this complication can lead to vision loss, creating an urgent need for early diagnosis and treatment of chronic diabetic retinopathy. This is, in turn, bolstering the demand and growth of the retinal imaging market.
Some of the prominent players operating in the market are:
- Olympus
- Robert Bosch GmbH
- Eyenuk, Inc.
- Imagine Eyes
- Optos, Plc.
- Forus Health Pvt. Ltd.
- Phoenix Technology Group, Inc.
- Topcon Corporation
- NIDEK Co. Ltd.
- Epipole, Ltd.
- Others
Request customization of the report: https://www.emergenresearch.com/request-for-customization/262
Detailed analysis of historical and current data to offer accurate forecast estimations till 2027
Analysis of the market drivers, restraints, growth prospects, limitations, lucrative growth opportunities, and threats
Strategic recommendations to the key players and new entrants to gain a robust footing in the market and ascertain maximum returns on their investments
Thorough SWOT analysis and Porter’s Five Forces analysis to offer a better understanding of the competition in the Global Retinal Imaging Market
An extensive regional analysis covering country-wise analysis and details about the regions showing promising growth
Some Notable Developments in the Competitive Landscape:
Optos and Amydis, in 2018, joined forces to create an eye test for the detection of Alzheimer’s disease, primarily developed by Amydis. Amydis is actively developing new pipeline drugs to detect the amyloid proteins in the retina by leveraging the optomap ultra-widefield retinal imaging device developed by Optos.
Bosch signed a partnership deal with Aravind Eye Care, a hospital chain in India, to educated women technicians on how to capture detailed eye images using the Fundus Camera developed by Bosch.
Retinal Imaging Market Segmentation
Device Type
- Fundus Camera
- Fluorescein Angiography
- Optical Coherence Tomography (OCT)
End-user Industry
- Hospitals
- Clinics
- Ophthalmic Centers
- Ambulatory Surgical Centers
- Others
Key questions addressed in the report:
What are the key factors driving the global Retinal Imaging market?
Who are the key manufacturers in this market space?
Who are the distributors, traders and dealers of this market?
What are the market opportunities and risks affecting the performance of the vendors in the global Retinal Imaging market?
What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?
Read More: https://www.emergenresearch.com/industry-report/retinal-imaging-market
Related Reports:
Neurostimulation Devices Market |
Mobile Robot Market |
Free Space Optics (FSO) CommunicationTechnologyMarket |
Anti-Aging Devices Market |
Thermoelectric Materials Market |
Airborne LiDAR Market |
Medical Wearables Market |
Medical Wearable Market |
Membrane Bioreactor Market |
Peristaltic Pumps Market |
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs